175 related articles for article (PubMed ID: 37389231)
1. Pre-transjugular-intrahepatic-portosystemic-shunt measurement of hepatic venous pressure gradient and its clinical application: A comparison study.
Wang XX; Yin XC; Gu LH; Guo HW; Cheng Y; Liu Y; Xiao JQ; Wang Y; Zhang W; Zou XP; Wang L; Zhang M; Zhu-Ge YZ; Zhang F
World J Gastroenterol; 2023 Jun; 29(22):3519-3533. PubMed ID: 37389231
[TBL] [Abstract][Full Text] [Related]
2. Endoscopic therapy + β-blocker vs. covered transjugular intrahepatic portosystemic shunt for prevention of variceal rebleeding in cirrhotic patients with hepatic venous pressure gradient ≥16 mmHg.
Guo H; Zhang F; Yin X; Zhang M; Xiao J; Wang Y; Zhang B; Zhang W; Zou X; Zhuge Y
Eur J Gastroenterol Hepatol; 2021 Nov; 33(11):1427-1435. PubMed ID: 32868650
[TBL] [Abstract][Full Text] [Related]
3. Second prophylaxis of variceal bleeding in cirrhotic patients with a high HVPG.
Zhang M; Wang G; Zhao L; Wu Z; Zhang W; Zhang C
Scand J Gastroenterol; 2016 Dec; 51(12):1502-1506. PubMed ID: 27379704
[TBL] [Abstract][Full Text] [Related]
4. Hepatic venous pressure gradient is a useful predictor in guiding treatment on prevention of variceal rebleeding in cirrhosis.
Li GQ; Yang B; Liu J; Wang GC; Yuan HP; Zhao JR; Liu JY; Li XP; Zhang CQ
Int J Clin Exp Med; 2015; 8(10):19709-16. PubMed ID: 26770635
[TBL] [Abstract][Full Text] [Related]
5. Prevention of variceal rebleeding in cirrhotic patients with spontaneous portosystemic shunts: transjugular intrahepatic portosystemic shunt versus endoscopic treatment.
Zhang H; Xiao J; Tu J; Zhang M; Zhang F; Yin Q; Zhuge Y
Eur J Gastroenterol Hepatol; 2021 May; 33(5):752-761. PubMed ID: 33731589
[TBL] [Abstract][Full Text] [Related]
6. Prevention of Rebleeding From Esophageal Varices in Patients With Cirrhosis Receiving Small-Diameter Stents Versus Hemodynamically Controlled Medical Therapy.
Sauerbruch T; Mengel M; Dollinger M; Zipprich A; Rössle M; Panther E; Wiest R; Caca K; Hoffmeister A; Lutz H; Schoo R; Lorenzen H; Trebicka J; Appenrodt B; Schepke M; Fimmers R;
Gastroenterology; 2015 Sep; 149(3):660-8.e1. PubMed ID: 25989386
[TBL] [Abstract][Full Text] [Related]
7. PTFE-covered TIPS is an effective treatment for secondary preventing variceal rebleeding in cirrhotic patients with high risks.
Zhou Y; Zhang W; Zhang Z; Luo J; Gu J; Liu Q; Ma J; Yan Z; Chen S; Wang J
Eur J Gastroenterol Hepatol; 2020 Sep; 32(9):1235-1243. PubMed ID: 32744824
[TBL] [Abstract][Full Text] [Related]
8. Episodic overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt does not increase mortality in patients with cirrhosis.
Nardelli S; Riggio O; Marra F; Gioia S; Saltini D; Bellafante D; Adotti V; Guasconi T; Ridola L; Rosi M; Caporali C; Fanelli F; Roccarina D; Bianchini M; Indulti F; Spagnoli A; Merli M; Vizzutti F; Schepis F
J Hepatol; 2024 Apr; 80(4):596-602. PubMed ID: 38097113
[TBL] [Abstract][Full Text] [Related]
9. Outcome of 100 patients after transjugular intrahepatic portosystemic shunt for variceal hemorrhage.
Sahagun G; Benner KG; Saxon R; Barton RE; Rabkin J; Keller FS; Rosch J
Am J Gastroenterol; 1997 Sep; 92(9):1444-52. PubMed ID: 9317060
[TBL] [Abstract][Full Text] [Related]
10. Analysis of prognostic variables in the prediction of mortality, shunt failure, variceal rebleeding and encephalopathy following the transjugular intrahepatic portosystemic stent-shunt for variceal haemorrhage.
Jalan R; Elton RA; Redhead DN; Finlayson ND; Hayes PC
J Hepatol; 1995 Aug; 23(2):123-8. PubMed ID: 7499782
[TBL] [Abstract][Full Text] [Related]
11. Transjugular intrahepatic portosystemic shunt prevents rebleeding in cirrhotic patients having cavernous transformation of the portal vein without improving their survival.
Li LN; Sun XY; Wang GC; Tian XG; Zhang MY; Jiang KT; Zhang CQ
J Dig Dis; 2019 Feb; 20(2):89-96. PubMed ID: 30629804
[TBL] [Abstract][Full Text] [Related]
12. Surgical portosystemic shunts versus transjugular intrahepatic portosystemic shunt for variceal haemorrhage in people with cirrhosis.
Brand M; Prodehl L; Ede CJ
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD001023. PubMed ID: 30378107
[TBL] [Abstract][Full Text] [Related]
13. [Comparison of the curative effect of transjugular intrahepatic portosystemic shunt with expanded polytetrafluoroethylene-covered stent and drug combined with gastroscopy as the secondary prevention of esophageal -gastric variceal bleeding in portal hypertension].
Lin ZP; Chen SL; Wang JY; Liu F; Tan Q; Peng QF; Zhao JB
Zhonghua Gan Zang Bing Za Zhi; 2020 Aug; 28(8):672-678. PubMed ID: 32911906
[No Abstract] [Full Text] [Related]
14. Eight millimetre covered TIPS does not compromise shunt function but reduces hepatic encephalopathy in preventing variceal rebleeding.
Wang Q; Lv Y; Bai M; Wang Z; Liu H; He C; Niu J; Guo W; Luo B; Yin Z; Bai W; Chen H; Wang E; Xia D; Li X; Yuan J; Han N; Cai H; Li T; Xie H; Xia J; Wang J; Zhang H; Wu K; Fan D; Han G
J Hepatol; 2017 Sep; 67(3):508-516. PubMed ID: 28506905
[TBL] [Abstract][Full Text] [Related]
15. Influence of portal hypertension and its early decompression by TIPS placement on the outcome of variceal bleeding.
Monescillo A; Martínez-Lagares F; Ruiz-del-Arbol L; Sierra A; Guevara C; Jiménez E; Marrero JM; Buceta E; Sánchez J; Castellot A; Peñate M; Cruz A; Peña E
Hepatology; 2004 Oct; 40(4):793-801. PubMed ID: 15382120
[TBL] [Abstract][Full Text] [Related]
16. Hepatic venous pressure gradient measurement before TIPS for acute variceal bleeding.
Qi XS; Fan DM
World J Gastroenterol; 2014 Jun; 20(23):7523-4. PubMed ID: 24966625
[TBL] [Abstract][Full Text] [Related]
17. Transjugular Intrahepatic Portosystemic Shunt:The Impact of Portal Venous Pressure Declines on Shunt Patency and Clinical Efficacy.
Wan YM; Li YH; Xu ZY; Wu HM; Wu XN; Xu Y; Guo T
Acad Radiol; 2019 Feb; 26(2):188-195. PubMed ID: 29934023
[TBL] [Abstract][Full Text] [Related]
18. Early TIPS with covered stents versus standard treatment for acute variceal bleeding in patients with advanced cirrhosis: a randomised controlled trial.
Lv Y; Yang Z; Liu L; Li K; He C; Wang Z; Bai W; Guo W; Yu T; Yuan X; Zhang H; Xie H; Yao L; Wang J; Li T; Wang Q; Chen H; Wang E; Xia D; Luo B; Li X; Yuan J; Han N; Zhu Y; Niu J; Cai H; Xia J; Yin Z; Wu K; Fan D; Han G;
Lancet Gastroenterol Hepatol; 2019 Aug; 4(8):587-598. PubMed ID: 31153882
[TBL] [Abstract][Full Text] [Related]
19. Transjugular intrahepatic portosystemic shunt vs endoscopic therapy in preventing variceal rebleeding.
Xue H; Zhang M; Pang JX; Yan F; Li YC; Lv LS; Yuan J; Palikhe M; Li WZ; Wang ZL
World J Gastroenterol; 2012 Dec; 18(48):7341-7. PubMed ID: 23326143
[TBL] [Abstract][Full Text] [Related]
20. Clinical Efficacy of Transjugular Intrahepatic Portosystemic Shunt Created with Expanded Polytetrafluoroethylene-Covered Stent-Grafts: 8-mm Versus 10-mm.
Luo X; Wang X; Zhu Y; Xi X; Zhao Y; Yang J; Li X; Yang L
Cardiovasc Intervent Radiol; 2019 May; 42(5):737-743. PubMed ID: 30643936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
